Last reviewed · How we verify
NCT04645979
A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico
trial testing Online survey in Rhinitis, Allergic in 153 participants. Completed in 27 November 2020.
27 November 2020
Quick facts
| Lead sponsor | Bayer |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 153 |
| Start date | 11 November 2020 |
| Primary completion | 27 November 2020 |
| Estimated completion | 27 November 2020 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Online survey
Conditions studied
- Rhinitis, Allergic — all drugs for Rhinitis, Allergic →
Sponsor
Bayer — full company profile →
Who can join
Adults 20 to 50, any sex, with Rhinitis, Allergic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever. In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04645979
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Online survey
Trials testing the same drug.
- NCT07460778 — Development of Serious Games for Rehabilitation: a Delphi Study · NA · recruiting
- NCT04788004 — Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse · active not recruiting
- NCT04974619 — Adaptation Of An HPV Education Resource To Promote HPV Vaccination · completed
- NCT04659473 — Spanish Survey on Third Wave of COVID-19 · unknown
- NCT03921476 — Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function · withdrawn
Other recruiting trials for Rhinitis, Allergic
Currently open trials in the same condition.
- NCT06535087 — The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life · recruiting
- NCT06427577 — Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites · NA · recruiting
- NCT05922176 — Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis · recruiting
- NCT05448066 — Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy · NA · recruiting
Other Bayer trials
Trials by the same sponsor.
- NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
- NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
- NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04645979 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bayer
- Last refreshed: 1 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04645979.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing